Cargando…

Advances in the pharmaceutical treatment options for canine osteoarthritis

Canine osteoarthritis is a significant cause of pain in many dogs and can therefore compromise animal welfare. As the understanding of the biology and pain mechanisms underpinning osteoarthritis grows, so do the number of treatments available to manage it. Over the last decade, there have been a num...

Descripción completa

Detalles Bibliográficos
Autores principales: Pye, C., Bruniges, N., Peffers, M., Comerford, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790257/
https://www.ncbi.nlm.nih.gov/pubmed/35285032
http://dx.doi.org/10.1111/jsap.13495
_version_ 1784859134730960896
author Pye, C.
Bruniges, N.
Peffers, M.
Comerford, E.
author_facet Pye, C.
Bruniges, N.
Peffers, M.
Comerford, E.
author_sort Pye, C.
collection PubMed
description Canine osteoarthritis is a significant cause of pain in many dogs and can therefore compromise animal welfare. As the understanding of the biology and pain mechanisms underpinning osteoarthritis grows, so do the number of treatments available to manage it. Over the last decade, there have been a number of advances in the pharmaceutical treatment options available for dogs with osteoarthritis, as well as an increasing number of clinical trials investigating the efficacy of pre‐existing treatments. This review aims to examine the current evidence behind pharmaceutical treatment options for canine osteoarthritis, including non‐steroidal anti‐inflammatory drugs, piprants, monoclonal antibodies, adjunctive analgesics, structure modifying osteoarthritis drugs and regenerative therapies.
format Online
Article
Text
id pubmed-9790257
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-97902572022-12-28 Advances in the pharmaceutical treatment options for canine osteoarthritis Pye, C. Bruniges, N. Peffers, M. Comerford, E. J Small Anim Pract Review Canine osteoarthritis is a significant cause of pain in many dogs and can therefore compromise animal welfare. As the understanding of the biology and pain mechanisms underpinning osteoarthritis grows, so do the number of treatments available to manage it. Over the last decade, there have been a number of advances in the pharmaceutical treatment options available for dogs with osteoarthritis, as well as an increasing number of clinical trials investigating the efficacy of pre‐existing treatments. This review aims to examine the current evidence behind pharmaceutical treatment options for canine osteoarthritis, including non‐steroidal anti‐inflammatory drugs, piprants, monoclonal antibodies, adjunctive analgesics, structure modifying osteoarthritis drugs and regenerative therapies. Blackwell Publishing Ltd 2022-03-14 2022-10 /pmc/articles/PMC9790257/ /pubmed/35285032 http://dx.doi.org/10.1111/jsap.13495 Text en © 2022 The Authors. Journal of Small Animal Practice published by John Wiley & Sons Ltd on behalf of British Small Animal Veterinary Association https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Pye, C.
Bruniges, N.
Peffers, M.
Comerford, E.
Advances in the pharmaceutical treatment options for canine osteoarthritis
title Advances in the pharmaceutical treatment options for canine osteoarthritis
title_full Advances in the pharmaceutical treatment options for canine osteoarthritis
title_fullStr Advances in the pharmaceutical treatment options for canine osteoarthritis
title_full_unstemmed Advances in the pharmaceutical treatment options for canine osteoarthritis
title_short Advances in the pharmaceutical treatment options for canine osteoarthritis
title_sort advances in the pharmaceutical treatment options for canine osteoarthritis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790257/
https://www.ncbi.nlm.nih.gov/pubmed/35285032
http://dx.doi.org/10.1111/jsap.13495
work_keys_str_mv AT pyec advancesinthepharmaceuticaltreatmentoptionsforcanineosteoarthritis
AT brunigesn advancesinthepharmaceuticaltreatmentoptionsforcanineosteoarthritis
AT peffersm advancesinthepharmaceuticaltreatmentoptionsforcanineosteoarthritis
AT comerforde advancesinthepharmaceuticaltreatmentoptionsforcanineosteoarthritis